mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-06 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-06 |